RGCC USA - Education and Support

RGCC Group, founded by Dr. Ioannis Papasotiriou in 2004, is dedicated to transforming global healthcare through innovative and personalized approaches to disease management, particularly in cancer care. By integrating advanced diagnostics, therapeutic development, and a robust clinical network, RGCC aims to ensure that breakthroughs in research translate into individualized treatment options for patients.

With divisions such as RGCC International, Welmedis, and Biocentaur, the company specializes in personalized therapies, targeted drug discovery, and reliable diagnostic tests, empowering patients to make informed healthcare decisions. RGCC's commitment to innovation, personalization, collaboration, and curiosity drives its mission to redefine the diagnosis, treatment, and management of diseases through a science-driven approach.

Generated from the website